Your search for supplemental oxygen returned 4 results

The studies evaluated routine clinical practice data from more than 800 hospitals in the US.

Actemra (tocilizumab) is an interleukin-6 receptor antagonist.

Kineret is an interleukin-1 receptor antagonist.

InflaRx is working to increase supply of the product in the US as quickly as possible.